Dr. Terry Wahls on how The Wahls Protocol came to be, and How to Launch Your Own Clinical Research Trial

Episode 79: Dr. Terry Wahls on how The Wahls Protocol came to be, and How to Launch Your Own Clinical Research Trial

We are all familiar with the Wahls Protocol. But how about the story behind the protocol? Did you know, for instance, that her director at U of Iowa (Terry is a clinician-researcher) told her to write up herself as a case report? That was the first step. Her “N of 1”; then she wrote up a case series. Then she received a small grant and product for a slightly larger study. Then a million dollars. And now she’s heading into her largest study to date (yes, you will be able to refer patients). Listen to our New Frontiers conversation on how YOU as a FxMed clinician can contribute to the body of research demonstrating that: What. We. Do. Works.

Episode 62: Methionine Metabolism and Methylation with Dr. David Quig

Episode 62: Sponsored | Methionine Metabolism and Methylation with Dr. David Quig

Methylation and sulfuration are complex processes and assessing them in practice takes skill, knowledge, and consideration of multiple genes and other factors. Lucky for us, we have the incredible Dr. David Quig from Doctor’s Data on the podcast today, getting into the nitty-gritty about assessing methylation in clinical practice.

Episode 60: Dutch™ Research And Validation In Peer-reviewed Journal Article

Episode 60: Dutch™ Research and Validation In Peer-Reviewed Journal Article

In today’s podcast, I chat with my friend and fellow laboratory geek Mark Newman, founder and president of Precision Analytical (creators of DUTCH), about his recent publication [Evaluating urinary estrogen and progesterone metabolites using dried filter paper samples and gas chromatography with tandem mass spectrometry (GC–MS/MS)], smartly published in an open access – and reputable – journal, BMC Chemistry, so it’s available to all, free of charge.

Episode 58: SPONSORED - Biocidin - Borrelia Research and Clinical Strategies using Botanical Antimicrobials

Episode 58: SPONSORED Biocidin – Borrelia Research and Clinical Strategies using Botanical Antimicrobials

Lyme disease (and co-infections) can be tough to treat. The Lyme spirochete, Borrelia burgdorferi, has adopted loads of devilishly clever cloaking devices – from thriving in biofilm to existing in pleomorphic forms – to ensure survival despite aggressive treatment. Enter botanical therapy. With or without concurrent antibiotics, botanical combinations are an essential component of the FxMed clinician’s toolkit.

Advances in Stool Testing: The GI-MAP™ GI-Microbial Assay Plus with Tony Hoffman

Episode 56: SPONSORED Advances in Stool Testing: The GI-MAP™ GI-Microbial Assay Plus with Tony Hoffman

I had loads of fun taking a tour through the wonderment of DSL GI MAP test today with Tony Hoffman, CEO of DSL (and longtime friend of mine!). DSL’s GI MAP stool test is, as CEO Tony Hoffman states, “a clinician diagnostic tool,” not a microbiome test. Yes, of course the GI MAP looks at the microbiome, but it’s not a broad sweep of the myriad bugs taking up residence.

Episode 54: SPONSORED Non-Alcoholic Fatty Liver Disease: Dr. Robert Rountree shares his Expertise (and Powerpoint!)

Non-alcoholic fatty liver disease is an urgent, often unrecognized concern. It’s the hepatic pandemic of the 21stcentury, and there is NO approved pharmaceutical therapy (the race is on, however…). Fortunately for us, there is MUCH we can do in functional medicine – indeed, our toolkit is powerfully effective in turning around NAFLD and even NASH – the next step progression.